Skip to main content
. 2022 Jul 27;4(9):e635–e645. doi: 10.1016/S2665-9913(22)00136-9

Table 2.

Ranked research avenues

Score Domain
Rank 1
Develop and test new treatments to prevent or reduce progression of musculoskeletal conditions. 18·0 LW
Rank 2
Identify the best ways to manage pain or improve quality of life. 16·5 LW
Rank 3
Develop and test approaches to help people with MSK conditions make lasting changes to improve their health. 16·0 LW
Develop and test ways to target and personalise treatments to each individual. 16·0 LW
Find out how to improve accurate and earlier diagnosis of MSK conditions. 16·0 D
Find out more about the benefits, safety, and best ways to use exercise or rehabilitation. 16·0 LW
Identify biological targets to develop new treatments that change the course of disease. 16·0 M
Identify disease processes that will allow better targeting of treatment to improve people's outcome. 16·0 M
Identify how to earlier predict the progress of MSK conditions. 16·0 M
Identify the best way to deliver the best support and information to help people effectively self-manage their condition. 16·0 LW
Identify the surgical techniques, technologies, and implants that help people the most. 16·0 LW
Identify tools, tests, and markers that can diagnose disease at an early stage and inform whether the disease will progress and respond to treatment. 16·0 M
Investigate how best to combine treatments. 16·0 LW
Study biological disease processes to identify ways to predict whether MSK conditions will develop or existing conditions will progress during someone's lifetime. 16·0 M
Study how chronic pain develops. 16·0 M
Study how new clinical, biological, and genetic and technology approaches can monitor the effectiveness of treatments. 16·0 T
Study how new clinical, biological, genetic, and technology approaches can improve diagnosis. 16·0 T
Study the effect of lifestyle (eg, work and exercise) on how MSK conditions develop and progress. 16·0 M
Study whether a better understanding of disease processes can be used to develop new ways of preventing MSK conditions. 16·0 M
Test new ways of making sure the right person gets the right treatment. 16·0 D
Understand disease processes so that we can better identify differences (subgroups of people) within the same condition. 16·0 M
Understand how MSK tissues repair themselves and how this could be enhanced to improve MSK conditions. 16·0 M
Understand the best ways of providing research-proven treatments to people, including where, when, and by whom. 16·0 T
Understand the links between tissue damage and pain. 16·0 M
Understand why people's pain experiences are different and why some people develop chronic pain when others do not. 16·0 M
Rank 4
Understand the biological links between MSK conditions and other illnesses. 15·5 M
Rank 5
Develop and test approaches to identify and help people with MSK conditions who need psychological support. 15·0 LW
Develop better ways to overcome the known difficulties in the process of turning a possible effective treatment into a safe, licensed product. 15·0 T
Find better ways to speed up the uptake of research results into treatment guidelines and policy. 15·0 T
Identify and find ways to address gaps in health-care professional knowledge about MSK conditions. 15·0 LW
Identify the best approaches to improving communication about MSK conditions between patients and their health-care professionals. 15·0 LW
Identify the best ways to improve outcomes after surgery. 15·0 LW
Improve how information from lab-based research and clinical trials is used to safely speed up making the best treatments available. 15·0 T
Investigate ways to speed up the process of turning scientific research findings into effective treatments. 15·0 T
Study how diet and gut bacteria can change the risk of developing MSK conditions. 15·0 M
Study how genes or ethnicity affect how MSK conditions develop. 15·0 M
Study how injury can lead to an increased risk of developing MSK conditions. 15·0 M
Study the role of inflammation in non-inflammatory MSK conditions. 15·0 M
Understand and overcome the barriers preventing research-proven tests and treatments being put into practice. 15·0 T
Understand how key biological disease processes drive development and progress of MSK conditions. 15·0 M
Understand how sex hormones and menopause change the risk of MSK conditions. 15·0 M
Rank 6
Better understand the benefit, safety, and use of existing medicines, including injections. 14·0 LW
Decide the best ways of delivering remote care for people. 14·0 LW
Define the risk factors in MSK conditions that might predict important outcomes or enable screening. 14·0 D
Identify any groups of patients or patterns within a condition that inform on the course or outcomes of MSK conditions. 14·0 D
Identify the best aids, supports, and other devices to help people live well. 14·0 LW
Identify the best lifestyle interventions. 14·0 LW
Set up and test new ways of using electronic health records for accurate, earlier diagnosis, and personalised monitoring. 14·0 D
Set up and test whether patients holding their own health data records helps them better manage their condition and make decisions with their clinician. 14·0 D
Study whether making changes to risk factors can prevent or delay the start of MSK conditions. 14·0 D
Study the best way of bringing together scientists, clinicians, industry, policy makers, and people with MSK conditions to improve the development of early research towards better available treatments. 14·0 T
Study the best way of sharing the results of research with clinicians, scientists, policy makers, and people with MSK conditions. 14·0 T
Study the best ways to measure the true effects of MSK conditions on individuals. 14·0 D
Test artificial intelligence approaches to analyse electronic health records and other large databases, (eg, of x-rays or scans) to improve care. 14·0 D
Test how clinical tools, tests, and markers can improve diagnosis. 14·0 D
Understand and address the reasons why everyone with a particular MSK condition does not have the same access to care. 14·0 LW
Understand and address the reasons why everyone with MSK conditions does not receive minimum standards of care. 14·0 LW
Understand and address the reasons why people have difficulty or delays accessing care. 14·0 LW
Understand and meet people's needs for monitoring and review of their condition. 14·0 LW
Understand how having an early diagnosis affects people, health care, and society. 14·0 D
Understand the best ways to diagnose and describe MSK conditions. Define features of relevant smaller groups within the same condition which make a difference to outcomes or care. 14·0 D
Understand the links between MSK and other long-term conditions, and the effect they have on people, work, and society. 14·0 D
Understand the reasons why diagnosis is sometimes delayed, and how best to reduce delays. 14·0 D
Rank 7
Find out how to produce a better estimate of the true cost of long-term MSK conditions to people and society. 13·0 D
Understand how changes in society, work, and people's circumstances, including finances, might lower the risk or effects of MSK conditions. 13·0 D
Rank 8
Study the pros and cons of screening for MSK conditions for people, health care, and society. 12·0 D
Study whether increasing public awareness of MSK conditions will encourage people to have a healthier lifestyle, get an earlier diagnosis, and better care. 12·0 D
Study whether new ways of collecting and using standard health data will improve people's care and help society. 12·0 D

Within each rank, avenues are presented in alphabetical order. LW=living well. D=diagnosis. T=translation. M=mechanisms.